Stay updated on Pimavanserin Relapse Prevention Clinical Trial
Sign up to get notified when there's something new on the Pimavanserin Relapse Prevention Clinical Trial page.

Latest updates to the Pimavanserin Relapse Prevention Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAdded a new record version v3.5.0 to the history; the previous v3.4.3 entry was removed.SummaryDifference0.1%

- Check26 days agoChange DetectedRevision v3.4.3 added to the history; revision v3.4.2 removed.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision: v3.4.2 was added to the history and an outdated funding notice was removed; these are minor site maintenance updates that do not affect trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check61 days agoChange DetectedA site-wide notice about government funding lapse and NIH Clinical Center operating status was added. The revision tag was updated from v3.4.0 to v3.4.1.SummaryDifference0.6%

- Check69 days agoChange DetectedUI changes include a glossary toggle and color-coded marks for additions and deletions, with the revision updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check76 days agoChange DetectedThe update adds revision v3.3.4 and removes v3.3.3, affecting only version metadata. No study data, eligibility criteria, results, or records are changed; to avoid alerts for small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pimavanserin Relapse Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pimavanserin Relapse Prevention Clinical Trial page.